TARRYTOWN, N.Y. — With eight SKUs on the market and a high-profile stock car driver endorsing its products, Prestige Brands’ line of Goody’s internal analgesics is continuing to gain traction with consumers.
(To view the full Category Review, click here.)
According to IRI data, the brand was one of only a handful in the internal analgesic tablet category to record a sales increase over the past year, increasing 6.5% to $39.4 million.
In a conference call with investors in August, Prestige Brands president and CEO Ron Lombardi cited two factors that have helped fuel that growth — Goody’s tie-in with NASCAR and driver Dale Earnhardt Jr., and the recent launch of two new products.
The debut earlier this year of a mixed-fruit flavored headache powder, the brand’s third headache powder, and a back and body shot that complements the headache relief shot already in the company’s lineup are in keeping with Prestige’s strategy of developing new products to grow its brands, Lombardi said.